Загрузка...
Use of synthetic adrenocorticotropic hormone in patients with IgA nephropathy
BACKGROUND: Synthetic adrenocorticotropic hormone (ACTH) has been demonstrated to be effective in patients with membranous nephropathy, minimal change disease and some histological subtypes of focal segmental glomerulosclerosis. Its clinical impact in patients with IgA nephropathy is currently uncle...
Сохранить в:
| Опубликовано в: : | BMC Nephrol |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5966849/ https://ncbi.nlm.nih.gov/pubmed/29792169 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-018-0915-4 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|